U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.216-29dup AND Hereditary cancer-predisposing syndrome

Germline classification:
Benign (1 submission)
Last evaluated:
May 27, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002255681.2

Allele description [Variation Report for NM_000465.4(BARD1):c.216-29dup]

NM_000465.4(BARD1):c.216-29dup

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.216-29dup
HGVS:
  • NC_000002.12:g.214792474dup
  • NG_012047.3:g.22253dup
  • NM_000465.4:c.216-29dupMANE SELECT
  • NM_001282543.2:c.159-29dup
  • NM_001282545.2:c.215+4587dup
  • NM_001282548.2:c.158+16938dup
  • NM_001282549.2:c.216-29dup
  • LRG_297t1:c.216-29dup
  • LRG_297:g.22253dup
  • NC_000002.11:g.215657198dup
  • NM_000465.2:c.216-14_216-13insT
  • NM_000465.4:c.216-14dupTMANE SELECT
Links:
dbSNP: rs56130510
NCBI 1000 Genomes Browser:
rs56130510
Molecular consequence:
  • NM_000465.4:c.216-29dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282543.2:c.159-29dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282545.2:c.215+4587dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282548.2:c.158+16938dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282549.2:c.216-29dup - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002529581Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Benign
(May 27, 2020)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From Sema4, Sema4, SCV002529581.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023